Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIFLUOPERAZINE Cause Weight increased? 159 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Weight increased have been filed in association with TRIFLUOPERAZINE (Trifluoperazine Hydrochloride). This represents 43.1% of all adverse event reports for TRIFLUOPERAZINE.

159
Reports of Weight increased with TRIFLUOPERAZINE
43.1%
of all TRIFLUOPERAZINE reports
0
Deaths
156
Hospitalizations

How Dangerous Is Weight increased From TRIFLUOPERAZINE?

Of the 159 reports, 156 (98.1%) required hospitalization, and 1 (0.6%) were considered life-threatening.

Is Weight increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIFLUOPERAZINE. However, 159 reports have been filed with the FAERS database.

What Other Side Effects Does TRIFLUOPERAZINE Cause?

Drug ineffective (198) Suicide attempt (161) Akathisia (152) Toxicity to various agents (151) Euphoric mood (148) Increased appetite (147) Obsessive-compulsive disorder (147) Antipsychotic drug level below therapeutic (145) Disinhibition (145) Therapeutic product effect variable (139)

What Other Drugs Cause Weight increased?

ADALIMUMAB (7,724) INFLIXIMAB (7,639) PREDNISONE (7,348) RISPERIDONE (6,885) METHOTREXATE (6,616) TOCILIZUMAB (6,425) RITUXIMAB (6,148) TOFACITINIB (5,342) ETANERCEPT (5,327) PREGABALIN (4,903)

Which TRIFLUOPERAZINE Alternatives Have Lower Weight increased Risk?

TRIFLUOPERAZINE vs TRIFLURIDINE TRIFLUOPERAZINE vs TRIHEPTANOIN TRIFLUOPERAZINE vs TRIHEXYPHENIDYL TRIFLUOPERAZINE vs TRILACICLIB TRIFLUOPERAZINE vs TRILEPTAL

Related Pages

TRIFLUOPERAZINE Full Profile All Weight increased Reports All Drugs Causing Weight increased TRIFLUOPERAZINE Demographics